Buy & Sell iShares Semiconductor ETF (SOXX) – iShares Semiconductor ETF Price Today
Aura AI Summary
Key Stats
- -Market Cap
- Sector/ThematicSector
- -15.82%3M Drawdown
- -Enterprise Value
- -Dividend Yield
- 41% Buy | 59% SellTrading Activity
- 14 daysTypical Hold Time
Over the past 52 weeks, iShares Semiconductor ETF has traded between a low of $202.56 and a high of $532.76, highlighting its annual price range. Over the past three months, iShares Semiconductor ETF has recorded a drawdown of -15.82%, reflecting recent price volatility. On average, investors hold iShares Semiconductor ETF for approximately 14 days, indicating typical investor behavior on the platform.
About iShares Semiconductor ETF
SOXX provides investors with exposure to U.S. companies that design, manufacture, and distribute semiconductors. It tracks the ICE Semiconductor Index, offering a targeted investment in the technology sector's foundational components, including firms that produce chips, related equipment, and services. SOXX is a key vehicle for investors seeking to capitalize on trends in artificial intelligence, 5G, and other technologies that rely heavily on advanced semiconductor technology.
Most Recent News
Anthropic acquires Stainless to enhance developer tools and API connections for $300M.
Anthropic has acquired Stainless, a startup specializing in developer tools for APIs, for approximately $300 million. Stainless, founded in 2022, has worked with major clients including Google DeepMind, Meta, and OpenAI, and developed software linked...
Boston Scientific invests $1.5B for stake in MiRus, targeting advanced aortic stenosis treatment.
Boston Scientific has invested $1.5 billion to acquire about a 34% stake in MiRus, gaining exclusive rights to its investigational transcatheter aortic valve replacement (TAVR) system designed for severe aortic stenosis. The SIEGEL valve features a n...
Elliott sees hidden value in Bio-Rad via $5B Sartorius stake amid share price slump
Activist investor Elliott Investment Management has taken a significant stake in Bio-Rad Laboratories, which develops medical instruments and software. Bio-Rad's founding family retains majority voting control, complicating activist efforts. Elliott ...